CR Bard Inc (BCR)

BCR (NYSE:Health Services) EQUITY
$170.93
neg -1.00
-0.59%
Today's Range: 170.54 - 172.15 | BCR Avg Daily Volume: 572,000
Last Update: 05/26/15 - 11:59 AM EDT
Volume: 71,902
YTD Performance: 3.20%
Open: $171.85
Previous Close: $171.95
52 Week Range: $135.80 - $180.94
Oustanding Shares: 74,245,736
Market Cap: 12,766,554,305
6-Month Chart
TheStreet Ratings Grade for BCR
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 1 1 1
Moderate Buy 1 1 1 1
Hold 11 11 11 11
Moderate Sell 0 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 2.64 2.86 2.86 2.86
Latest Dividend: 0.22
Latest Dividend Yield: 0.51%
Dividend Ex-Date: 04/23/15
Price Earnings Ratio: 46.22
Price Earnings Comparisons:
BCR Sector Avg. S&P 500
46.22 46.20 27.04
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-2.86% 17.58% 74.23%
GROWTH 12 Mo 3 Yr CAGR
Revenue 9.00 0.15 0.05
Net Income -57.30 -0.10 -0.03
EPS -55.30 0.02 0.01
Earnings for BCR:
EBITDA 0.96B
Revenue 3.32B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $2.17 $2.28 $9.01 $9.94
Number of Analysts 12 11 14 13
High Estimate $2.20 $2.31 $9.03 $10.11
Low Estimate $2.14 $2.23 $8.98 $9.50
Prior Year $2.06 $2.15 $8.40 $9.01
Growth Rate (Year over Year) 5.50% 5.92% 7.25% 10.37%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bullish
Apr 24, 2015 | 8:14 AM EDT
BCR was upgraded from Neutral to Buy, Bank of America/Merrill Lynch said. $200 price target. See higher growth from the drug eluting ba...
Traders should be looking for shorting opportunities.
Bullish
Jan 20, 2015 | 7:30 AM EST
BCR was upgraded from Underweight to Neutral, JP Morgan said. Lutonix and drug-coated ballons could exceed expectations. 
Bearish
Jan 05, 2015 | 7:51 AM EST
BCR was downgraded from Neutral to Underweight, JP Morgan said. Valuation call, based on a $162 price target. 
Bullish
Jan 05, 2015 | 6:43 AM EST
BCR was upgraded to Equal-weight from Underweight, Morgan Stanley said. $187 price target. Company has significant earnings flexibility...
Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

Some Stocks to Watch Today Real Money Pro($)

Though broad futures have improved somewhat.
There's a powerful collection of "what's working."
These stocks are all worth your consideration.
A wave of M&A in the health sector makes sense.

Columnist Conversations

Today we have a big rise in volatility and other areas as well, the implied correlation index (ICJ) is also ra...
After a very flat pre-holiday week in trading, market starts the shortened week on the downside. The game of ...
Seems like the selling is a little overdone....
The Germany iShares (EWG) fund has been unable to make a new closing high this month, and diverged from the S&...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.